Family Matters: Jane and Dorothy Batten Are on a Mission to Advance Focused Ultrasound
By any measure, the Batten family ranks among the most impactful philanthropists of our time, playing a major role in enhancing the educational and cultural resources of Virginia.
Known for their influence and generosity, Jane (mother) and Dorothy (daughter) are presented with countless opportunities to support worthy causes. And yet, “No family has done more to accelerate the widespread adoption of focused ultrasound than the Battens,” said Neal F. Kassell, MD, the founder and chairman of the Focused Ultrasound Foundation. “They wholeheartedly share in our mission to improve the lives of millions of people with this revolutionary technology, and we have been incredibly fortunate to benefit from their devotion and philanthropy.”
Call for Comments: Guidelines for Focused Ultrasound Treatment Reporting
Focused ultrasound is a versatile technology that can interact with tissue in diverse ways to produce more than 18 different bioeffects. This versatility makes focused ultrasound a potential treatment for more than 130 medical conditions. However, without clear standardization of treatment reporting and methodologies for measuring and describing key parameters for preclinical and clinical investigations, these diverse “modes” of focused ultrasound can also present a unique barrier to widespread clinical translation.
A general challenge often discussed at the Foundation’s workshops and symposia is the difficulty comparing treatment parameters from one focused ultrasound device to another. Furthermore, with no consistent standards for measurements and reporting, it can be impossible to reproduce results across multiple laboratories. The consensus view has identified the need for a set of guidelines to recommend key parameters to report and measurement methodologies to use; the aim would be for the entire focused ultrasound community to begin using these guidelines for future research.
In recent months, the Focused Ultrasound Foundation has drafted guidelines, with the input of several focused ultrasound scientific and technical experts, and we are pleased to invite public comment on a draft of this document.
To ensure consistency in the reporting of focused ultrasound treatment parameters, which will enable cross-comparison of studies performed by different groups and/or with different systems;
To provide guidelines for assessing and reporting bioeffects associated with different focused ultrasound treatment regimens, which is necessary for cross-comparison of studies and validation of therapeutic bioeffects;
To provide guidelines for testing focused ultrasound systems and protocols.
The Foundation is seeking public comments on these guidelines to ensure that they are comprehensive and address challenges faced by the community. The public comment period is open until July 15, 2020.